XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
167 hedge funds and large institutions have $2.56B invested in Acceleron Pharma in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 58 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 27
12% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 58
Holders
167
Holding in Top 10
9
Calls
$38.9M
Puts
$7.86M
Top Buyers
| 1 | +$143M | |
| 2 | +$48.6M | |
| 3 | +$26.9M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$25.2M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$22.3M |
Top Sellers
| 1 | -$26M | |
| 2 | -$22.9M | |
| 3 | -$21M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19.7M |
| 5 |
Morgan Stanley
New York
|
-$9.69M |